Effect of pretreatment regimens of 1-aminobenzotriazole on metabolism and gastric emptying of probe compounds in rat

References

• Amekyeh H, Billa N, Yuen KH, et al. (2015). A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats. AAPS Pharm Sci Tech 16:871–7.
   PubMed Web of Science ®Google Scholar
• Balani SK, Zhu T, Yang TJ, et al. (2002). Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Drug Metab Dispos 30:1059–62.
   PubMed Web of Science ®Google Scholar
• Boily MO, Chauret N, Laterreur J, et al. (2015). In vitro and in vivo mechanistic studies toward understanding the role of 1-aminobenzotriazole in rat drug-drug interactions. Drug Metab Dispos 43:1960–5.
   PubMed Web of Science ®Google Scholar
• Caldwell GW, Ritchie DM, Masucci JA, et al. (2005). The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens. Eur J Drug Metab Pharmacokinet 30:75–83.
   PubMed Web of Science ®Google Scholar
• Dos Santos EA, Dahly-Vernon AJ, Hoagland KM, et al. (2004). Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis. Am J Physiol Regul Integr Comp Physiol 287:R58–68.
   PubMed Web of Science ®Google Scholar
• El-Kattan AF, Poe J, Buchholz L, et al. (2008). The use of 1-aminobenzotriazole in differentiating the role of CYP-mediated first pass metabolism and absorption in limiting drug oral bioavailability: a case study. Drug Metab Lett 2:120–4.
   PubMedGoogle Scholar
• Emoto C, Murase S, Sawada Y, et al. (2003). In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole. Drug Metab Pharmacokinet 18:287–95.
   PubMedGoogle Scholar
• Kole P, Rao A, Kurawattimath V, et al. (2017). LC-MS determination of triazolam and its hydroxy metabolites in mouse dried blood spots: application to transgenic mouse pharmacokinetic studies. Bioanalysis 9:987–1000.
   PubMed Web of Science ®Google Scholar
• Kurasawa T, Chikaraishi Y, Naito A, et al. (2005). Effect of humulus lupulus on gastric secretion in a rat pylorus-ligated model. Biol Pharm Bull 28:353–7.
   PubMed Web of Science ®Google Scholar
• Kuze J, Mutoh T, Takenaka T, et al. (2013). Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam. Xenobiotica 43:598–606.
   PubMed Web of Science ®Google Scholar
• Linder CD, Renaud NA, Hutzler JM. (2009). Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator?. Drug Metab Dispos 37:10–3.
   PubMed Web of Science ®Google Scholar
• Meschter CL, Mico BA, Mortillo M, et al. (1994). A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats. Fundam Appl Toxicol 22:369–81.
   PubMedGoogle Scholar
• Mico BA, Federowicz DA, Ripple MG, et al. (1988). In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). A tool for biochemical toxicology. Biochem Pharmacol 37:2515–9.
   PubMed Web of Science ®Google Scholar
• Mizuta H, Kawazoe Y, Haga K, et al. (1990). Effects of meals on gastric emptying and small intestinal transit times of a suspension in the beagle dog assessed using acetaminophen and salicylazosulfapyridine as markers. Chem Pharm Bull (Tokyo) 38:2224–7.
   PubMed Web of Science ®Google Scholar
• Mizuta H, Kawazoe Y, Ogawa K. (1990). Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog. Chem Pharm Bull (Tokyo) 38:2810–3.
   PubMed Web of Science ®Google Scholar
• Mugford CA, Mortillo M, Mico BA, et al. (1992). 1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats. Fundam Appl Toxicol 19:43–9.
   PubMedGoogle Scholar
• Parrish KE, Mao J, Chen J, et al. (2016). In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in rats. Biopharm Drug Dispos 37:200–11.
   PubMed Web of Science ®Google Scholar
• Perloff MD, von Moltke LL, Court MH, et al. (2000). Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. J Pharmacol Exp Ther 292:618–28.
   PubMed Web of Science ®Google Scholar
• Prescott LF. (1980). Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol 10 Suppl 2:291S–8S.
   PubMed Web of Science ®Google Scholar
• Sodhi JK, Ford KA, Mukadam S, et al. (2014). 1-Aminobenzotriazole coincubated with (S)-warfarin results in potent inactivation of CYP2C9. Drug Metab Dispos 42:813–7.
   PubMed Web of Science ®Google Scholar
• Strelevitz TJ, Foti RS, Fisher MB. (2006). In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance. J Pharm Sci 95:1334–41.
   PubMed Web of Science ®Google Scholar
• Stringer RA, Weber E, Tigani B, et al. (2014). 1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats. Drug Metab Dispos 42:1117–24.
   PubMed Web of Science ®Google Scholar
• Subramanian R, Aidasani D, Bailey K, et al. (2014). P450-mediated O-demethylated metabolite is responsible for rat hepatobiliary toxicity of pyridyltriazine-containing PI3K inhibitors. Toxicol Sci 142:298–310.
   PubMed Web of Science ®Google Scholar
• Sun Q, Harper TW, Dierks EA, et al. (2011). 1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase. Drug Metab Dispos 39:1674.
   PubMed Web of Science ®Google Scholar
• Vinay HK, Paul A, Goswami SS, et al. (2002). Effect of SR 58611A, a beta-3 receptor agonist, against experimental gastro-duodenal ulcers. Indian J Physiol Pharmacol 46:36–44.
   PubMedGoogle Scholar
• Warrington JS, Greenblatt DJ, Von Moltke LL. (2004). Role of CYP3A enzymes in the biotransformation of triazolam in rat liver. Xenobiotica 34:463–71.
   PubMed Web of Science ®Google Scholar